Recurrent Adult Diffuse Small Cleaved Cell Lymphoma Terminated Phase 1 Trials for Lipoic acid (DB00166)
| Indication | Status | Phase |
|---|---|---|
| DBCOND0028499 (Recurrent Adult Diffuse Small Cleaved Cell Lymphoma) | Terminated | 1 |
| clinicaltrials.gov Identifier | Title | Purpose | Drugs |
|---|---|---|---|
| NCT02168907 | CPI-613, Bendamustine Hydrochloride, and Rituximab in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma | Treatment |